Stem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions

Area of Science:

• Neurology
• Endocrinology
• Regenerative Medicine

Background:

• Diabetic polyneuropathy (DPN) is a frequent complication of long-term diabetes, affecting a significant portion of patients.
• Current treatment options for DPN are limited, with no definitive cure available.
• The incidence rate of DPN is approximately 2% annually.

Purpose of the Study:

• To review the epidemiology, classification, and current treatment options for DPN.
• To explore the potential of cell-based therapies as a treatment for DPN.
• To highlight the role of cryotherapies in managing DPN.

Main Methods:

• Review of existing literature on DPN epidemiology, classification, and treatments.
• Focus on various cell-based therapeutic approaches, including stem cells and progenitor cells.
• Examination of studies investigating cryotherapy for DPN.

Main Results:

• Cell-based therapies utilizing bone marrow-derived cells, embryonic stem cells, pluripotent stem cells, endothelial progenitor cells, mesenchymal stem cells, and dental pulp stem cells are identified as promising treatment avenues.
• Cryotherapies have demonstrated importance in several studies for treating DPN.
• Cell-based therapy may offer a permanent solution for DPN management.

Conclusions:

• Cell-based therapies represent a vital candidate for the treatment of DPN.
• Further research into cell-based and cryotherapies could lead to more effective and safer treatments for DPN.
• Cell-based therapy holds potential as a permanent solution for diabetes-induced neuropathy.